Sermorelin (10mg)

Pharmaceutical-grade research peptide, lyophilized for stability. Each batch is independently tested and COA-verified with ≥99% purity by HPLC analysis. Intended exclusively for research purposes.

Sermorelin is studied as a GHRH analogue that can stimulate the pituitary gland to release growth hormone. The literature describes its use in GH deficiency diagnostics, paediatric growth studies and research on the GH/IGF-1 axis. Historically, sermorelin has been investigated as a diagnostic provocation test for growth hormone deficiency and as a treatment in selected paediatric contexts. In adult settings, research explores endogenous GH stimulation, though broad anti-ageing or performance claims are not well supported by the evidence base.

For laboratory research use only. This information describes areas of scientific investigation and does not constitute medical advice, dosing guidance or therapeutic claims.